Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07580222 · ClinicalTrials.gov registry record
Mobile Technology to Measure Knee Health in Osteoarthritis
A clinical trial, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- 47
- Enrollment target
NCT07580222: Recruiting study, sponsored by VA Office of Research and Development.
NCT07580222 is a clinical trial that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07580222 is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- 47 participants
- Enrollment target
Study Summary
Veterans face a high prevalence of knee osteoarthritis (OA), but current diagnostic methods often miss early stages when interventions are more effective. This project will evaluate smartphone-based motion capture via OpenCap to measure joint mechanics in knee OA patients during functional activities, comparing its performance to a conventional motion capture system, patient-reported symptoms, and knee joint structure. The findings will have the potential to enable clinicians to trial OpenCap in its current form, provide insights into tracking joint health, and guide refinements to advance toward earlier diagnosis of knee OA by complementing symptom assessments with measures of joint mechanics.
Primary Outcome
Knee flexion angle extracted from functional activities (e.g., walking, chair-to-stand)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2028-03-31 |
What NCT07580222 shows while recruiting
NCT07580222 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07580222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07580222 about?
NCT07580222 is a clinical study titled "Mobile Technology to Measure Knee Health in Osteoarthritis". Veterans face a high prevalence of knee osteoarthritis (OA), but current diagnostic methods often miss early stages when interventions are more effective. This project will evaluate smartphone-based motion capture via OpenCap to measure joint mechanics in knee OA patients during functional activitie...
What is the current status of trial NCT07580222?
This trial is currently recruiting. The enrollment target is 47 participants. The study started on 2026-04-01. Estimated completion is 2028-03-31.
Who is sponsoring clinical trial NCT07580222?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI